Lead the identification, development, and application of innovative statistical methodologies for clinical development programs.
Provide expert statistical consultation and shape statistical strategies for clinical trial design and analysis.
Mentor statisticians and build a statistical innovation team to foster methodological excellence.
Alnylam is the leader in RNAi therapeutics, a revolutionary approach with the potential to transform the lives of people with rare and common diseases. The company is a globally recognized top employer with an authentic, inclusive culture and a deep pipeline, late-stage programs, and a bold vision.
Set the statistical vision and direction for clinical studies spanning early feasibility through post-market evidence generation.
Manage a portfolio of 10+ projects, represent Biostatistics with regulatory agencies, and lead external scientific engagements.
Drive process improvement, mentorship, and AI-enabled productivity across the biostatistics team.
We are a global leader in robotic-assisted surgery and minimally invasive care, with technologies like the da Vinci surgical system. We are a team of engineers, clinicians, and innovators united by one purpose: to make surgery smarter, safer, and more human.
Lead the clinical development strategy for AL137, owning the medical strategy for Phase 1 and shaping the path toward later-stage development.
Provide medical leadership for protocol design, safety considerations, dose escalation, and data interpretation in early clinical trials.
Serve as the internal physician expert, integrating AI technologies to accelerate analysis and improve decision-making.
Alector develops therapies that empower the immune system to combat neurodegeneration. The company is supported by experienced scientists, leading healthcare investors, and pharma partners, fostering a dynamic and flexible culture that encourages experimentation and ownership.